The release of VEGFA and semaphorin 3A (Sema 3A) by tumor cells, including glioma, further activates NRP1, triggering the activation of VEGFR1 and subsequent recruitment of TAMs in glioma [22]. Here, SEMA3A is linked to central nervous system cancer.